Michael Asensio
Associate Director, Antibody Discovery at GigaGen Inc - South San Francisco, California, United States
Michael Asensio's Colleagues at GigaGen Inc
Alexis Enstrom
Research Associate - Antibody Engineering & Technology Development
Michael Asensio's Contact Details
San Francisco,California,United States
GigaGen Inc
Michael Asensio's Company Details
GigaGen, a subsidiary of Grifols, is advancing transformative antibody drugs for immune deficiency, infectious diseases and checkpoint resistant cancers by leveraging industry-leading, single-cell technologies.GigaGen's novel technology platforms uniquely capture and recreate complete immune repertoires as functional antibody libraries. This approach has enabled the creation of first-in-class recombinant polyclonal antibody therapies for the treatment of infectious diseases.GigaGen's lead oncology asset, GIGA-564, is an anti-CTLA-4 monoclonal antibody that has demonstrated improved anti-tumor efficacy in vivo through a unique mechanism of action.GigaGen is leveraging its proprietary technology platforms for the continued discovery of novel recombinant polyclonal drugs and monoclonal antibodies to treat life-threatening diseases.